NCT02578069View on ClinicalTrials.gov

First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial)

NACompletedINTERVENTIONAL
Enrollment

272

Participants

Timeline

Start Date

April 27, 2015

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Ischemic Stroke
Interventions
DEVICE

NOVA Intracranial Sirolimus Eluting Stent System

A sirolimus eluting intracranial stent system with polylactic-co-glycolic acid (PLGA) biodegradable drug carrier and electro-grated polybutyl methacrylate (PBMA) base coating. The stent platform is made of 316L stainless steel.

DEVICE

Apollo Intracranial Stent System

A 316L stainless steel balloon-expandable intracranial stent system

Trial Locations (1)

100050

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
collaborator

Beijing Tiantan Hospital

OTHER

lead

Sino Medical Sciences Technology Inc.

INDUSTRY

NCT02578069 - First-in-man Trial Evaluating the Safety and Efficacy of the NOVA Intracranial Stent (NOVA Trial) | Biotech Hunter | Biotech Hunter